Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.85 USD | +4.90% | +3.79% | -12.37% |
13/05 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
13/05 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.37% | 456M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Theravance Biopharma : Needham Adjusts Theravance Biopharma's Price Target to $18 From $32, Keeps Buy Rating